WPC
TEVA icon

White Pine Capital’s Teva Pharmaceuticals TEVA Stock Holding History

White Pine Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,617
Closed -$253K – 223
2017
Q2 		$253K Sell
7,617
-500
-6% -$15.5K 0.1% 189
2017
Q1 		$260K Sell
8,117
-2,950
-27% -$101K 0.11% 180
2016
Q4 		$401K Sell
11,067
-3,785
-25% -$151K 0.17% 147
2016
Q3 		$683K Hold
14,852
– – 0.29% 95
2016
Q2 		$746K Sell
14,852
-300
-2% -$16K 0.31% 90
2016
Q1 		$811K Sell
15,152
-849
-5% -$49.8K 0.35% 83
2015
Q4 		$1.05M Sell
16,001
-485
-3% -$30K 0.46% 61
2015
Q3 		$931K Sell
16,486
-70
-0.4% -$4.54K 0.43% 61
2015
Q2 		$978K Sell
16,556
-7,450
-31% -$460K 0.42% 75
2015
Q1 		$1.5M Sell
24,006
-12,875
-35% -$749K 0.61% 45
2014
Q4 		$2.12M Sell
36,881
-350
-0.9% -$19.5K 0.71% 38
2014
Q3 		$2M Buy
37,231
+7,710
+26% +$408K 0.68% 37
2014
Q2 		$1.55M Sell
29,521
-850
-3% -$43.4K 0.53% 62
2014
Q1 		$1.6M Sell
30,371
-183
-0.6% -$8.46K 0.55% 59
2013
Q4 		$1.23M Sell
30,554
-7,050
-19% -$278K 0.43% 70
2013
Q3 		$1.42M Sell
37,604
-12,300
-25% -$480K 0.49% 65
2013
Q2 		$1.96M Buy
+49,904
New +$1.94M 0.68% 46

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

White Pine Capital's TEVA Position: Q3 2017 in Review

White Pine Capital sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 7,617 shares — an estimated $253K sold.

White Pine Capital first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.12M in Q4 2014. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • White Pine Capital reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • White Pine Capital sold 7,617 Teva Pharmaceuticals shares in Q3 2017, an estimated $253K.
  • White Pine Capital first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • White Pine Capital's Teva Pharmaceuticals position peaked at $2.12M in Q4 2014.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on White Pine Capital's 13F filing for Q3 2017, filed 13 Nov 2017.